Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan J Flach

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
American Journal of Ophthalmology|February 17, 2009
Debunking myths in physician-industry conflicts of interestAllan J Flach
Transactions of the American Ophthalmological Society|March 12, 2009
The importance of eyelid closure and nasolacrimal occlusion following the ocular instillation of topical glaucoma medications, and the need for the universal inclusion of one of these techniques in all patient treatments and clinical studiesAllan J Flach
Archives of Ophthalmology (Chicago, Ill. : 1960)|September 16, 2009
Proposed mandate for instructions and labeling regarding the use of eye dropsAllan J Flach
Ophthalmology|October 5, 2011
Amsler grids for chloroquine toxicityAllan J Flach
Transactions of the American Ophthalmological Society|April 23, 2008
Improving the risk-benefit relationship and informed consent for patients treated with hydroxychloroquineAllan J Flach
Transactions of the American Ophthalmological Society|January 28, 2003
Delta-9-tetrahydrocannabinol (THC) in the treatment of end-stage open-angle glaucomaAllan J Flach
Cornea|December 19, 2006
Misuse and abuse of topically applied nonsteroidal anti-inflammatory drugsAllan J Flach
Transactions of the American Ophthalmological Society|February 4, 2010
Intraoperative floppy iris syndrome: pathophysiology, prevention, and treatmentAllan J Flach
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|August 24, 2004
Efficacy of low concentrations of ketorolac tromethamine in animal models of ocular inflammationL David Waterbury, Allan J Flach
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|July 1, 2006
Comparison of ketorolac tromethamine, diclofenac sodium, and loteprednol etabonate in an animal model of ocular inflammationL David Waterbury, Allan J Flach
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
American Journal of Ophthalmology|February 17, 2009
Debunking myths in physician-industry conflicts of interestAllan J Flach
Transactions of the American Ophthalmological Society|March 12, 2009
The importance of eyelid closure and nasolacrimal occlusion following the ocular instillation of topical glaucoma medications, and the need for the universal inclusion of one of these techniques in all patient treatments and clinical studiesAllan J Flach
Archives of Ophthalmology (Chicago, Ill. : 1960)|September 16, 2009
Proposed mandate for instructions and labeling regarding the use of eye dropsAllan J Flach
Ophthalmology|October 5, 2011
Amsler grids for chloroquine toxicityAllan J Flach
Transactions of the American Ophthalmological Society|April 23, 2008
Improving the risk-benefit relationship and informed consent for patients treated with hydroxychloroquineAllan J Flach
Transactions of the American Ophthalmological Society|January 28, 2003
Delta-9-tetrahydrocannabinol (THC) in the treatment of end-stage open-angle glaucomaAllan J Flach
Cornea|December 19, 2006
Misuse and abuse of topically applied nonsteroidal anti-inflammatory drugsAllan J Flach
Transactions of the American Ophthalmological Society|February 4, 2010
Intraoperative floppy iris syndrome: pathophysiology, prevention, and treatmentAllan J Flach
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|August 24, 2004
Efficacy of low concentrations of ketorolac tromethamine in animal models of ocular inflammationL David Waterbury, Allan J Flach
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|July 1, 2006
Comparison of ketorolac tromethamine, diclofenac sodium, and loteprednol etabonate in an animal model of ocular inflammationL David Waterbury, Allan J Flach
Pageof 2